Bank of America started coverage on shares of Afya (NASDAQ:AFYA) in a report released on Thursday morning, The Fly reports. The firm issued a buy rating and a price objective on the stock.
A number of other brokerages also recently issued reports on AFYA. Zacks Investment Research downgraded Afya from a hold rating to a sell rating in a research report on Wednesday, January 1st. UBS Group raised their target price on Afya from $29.00 to $31.00 and gave the company a buy rating in a report on Wednesday, January 15th. Finally, ValuEngine downgraded Afya from a hold rating to a sell rating in a research report on Tuesday, October 1st. Two investment analysts have rated the stock with a sell rating, one has assigned a hold rating and four have issued a buy rating to the company. The company currently has an average rating of Hold and a consensus price target of $30.70.
Shares of AFYA stock traded down $0.08 during trading hours on Thursday, hitting $28.85. The company’s stock had a trading volume of 141,447 shares, compared to its average volume of 189,465. Afya has a 12-month low of $21.30 and a 12-month high of $34.87. The stock has a 50 day simple moving average of $27.89. The company has a debt-to-equity ratio of 0.13, a current ratio of 2.92 and a quick ratio of 2.92.
Afya (NASDAQ:AFYA) last issued its earnings results on Monday, December 2nd. The company reported $0.18 earnings per share (EPS) for the quarter, topping the Thomson Reuters’ consensus estimate of $0.11 by $0.07. The business had revenue of $52.15 million for the quarter, compared to analysts’ expectations of $48.27 million. As a group, sell-side analysts forecast that Afya will post 0.5 earnings per share for the current year.
A number of large investors have recently bought and sold shares of the stock. Russell Investments Group Ltd. acquired a new stake in Afya in the third quarter valued at $13,760,000. Third Point LLC purchased a new stake in Afya during the third quarter worth approximately $10,256,000. Millennium Management LLC purchased a new stake in Afya during the third quarter worth approximately $10,189,000. Gilder Gagnon Howe & Co. LLC acquired a new position in Afya in the third quarter valued at approximately $8,782,000. Finally, JGP Global Gestao de Recursos Ltda. acquired a new position in Afya in the third quarter valued at approximately $7,961,000. 16.51% of the stock is currently owned by hedge funds and other institutional investors.
Afya Company Profile
Afya Limited, through its subsidiaries, operates as a medical education group in Brazil. The company provides educational products and services, including medical schools, medical residency preparatory courses, graduate courses, and other programs to lifelong medical learners enrolled across its distribution network, as well as to third-party medical schools.
See Also: How to Trade Using Analysts Ratings
Receive News & Ratings for Afya Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Afya and related companies with MarketBeat.com's FREE daily email newsletter.